RESULTS OF THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
|Download file (102 K)|
The GM passed the following resolution unanimously:
“THAT the payment of a dividend out of the profit of the Company according to the audited separate financial statements prepared for 2019 in the amount of RUR 1 389 812 685 including:
∙ RUR 1 035 820 201,49 – the net income received for 2019,
∙ RUR 107 300 601,05 – the part of the undistributed profit for 2018,
∙ RUR 246 691 882,46 – the part of the undistributed profit for 2017
or in the amount of RUR 18,50 per share, as proposed in the directors’ report be and is hereby approved. Subject to shareholders’ approval of the dividend at the extraordinary general meeting of shareholders of the Company, the dividend record date is set as September 16, 2020. The Global Depository Receipts will be marked as ex-dividend on September 15, 2020. The pay date for GDR holders is set as October 13, 2020. The payment shall be made in USD at the rate of the Central Bank of Russia on the 11 August 2020.”
The minutes of the GM will be available for viewing at the registered office of the Company at office 9-2, bld. 3, 6 Azovskaya str., Moscow, Russian Federation and will be available at the National Storage Mechanism of the UK Listing Authority, located at https://data.fca.org.uk/, in due course.
For further information please contact:
MD Medical Group Investments Plc
+7 (495) 139 87 40 ext. 16329
Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, Vladivostok, Krasnodar and Rostov-on-Don.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2020 2019 2018 2017 2016 2015 2014 2013 2012